Cancer Prevention Pharmaceuticals, Inc. S-1

Accession 0001144204-15-072415

CIK 0001471002other

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 22, 9:56 PM ET

Size

10.0 MB

Accession

0001144204-15-072415

Documents

73 files

S-1
v427012_s1.htmPrimary
S-1
EX-3.1
v427012_ex3-1.htm
EXHIBIT 3.1
EX-3.2
v427012_ex3-2.htm
EXHIBIT 3.2
EX-3.3
v427012_ex3-3.htm
EXHIBIT 3.3
EX-3.4
v427012_ex3-4.htm
EXHIBIT 3.4
EX-4.1
v427012_ex4-1.htm
EXHIBIT 4.1
EX-4.2
v427012_ex4-2.htm
EXHIBIT 4.2
EX-4.3
v427012_ex4-3.htm
EXHIBIT 4.3
EX-4.4
v427012_ex4-4.htm
EXHIBIT 4.4
EX-4.5
v427012_ex4-5.htm
EXHIBIT 4.5
EX-4.6
v427012_ex4-6.htm
EXHIBIT 4.6
EX-4.7
v427012_ex4-7.htm
EXHIBIT 4.7
EX-4.8
v427012_ex4-8.htm
EXHIBIT 4.8
EX-4.9
v427012_ex4-9.htm
EXHIBIT 4.9
EX-4.12
v427012_ex4-12.htm
EXHIBIT 4.12
EX-4.13
v427012_ex4-13.htm
EXHIBIT 4.13
EX-4.14
v427012_ex4-14.htm
EXHIBIT 4.14
EX-10.1
v427012_ex10-1.htm
EXHIBIT 10.1
EX-10.2
v427012_ex10-2.htm
EXHIBIT 10.2
EX-10.3
v427012_ex10-3.htm
EXHIBIT 10.3
EX-10.4
v427012_ex10-4.htm
EXHIBIT 10.4
EX-10.5
v427012_ex10-5.htm
EXHIBIT 10.5
EX-10.6
v427012_ex10-6.htm
EXHIBIT 10.6
EX-10.7
v427012_ex10-7.htm
EXHIBIT 10.7
EX-10.8
v427012_ex10-8.htm
EXHIBIT 10.8
EX-10.9
v427012_ex10-9.htm
EXHIBIT 10.9
EX-10.10
v427012_ex10-10.htm
EXHIBIT 10.10
EX-10.11
v427012_ex10-11.htm
EXHIBIT 10.11
EX-10.12
v427012_ex10-12.htm
EXHIBIT 10.12
EX-10.13
v427012_ex10-13.htm
EXHIBIT 10.13
EX-10.14
v427012_ex10-14.htm
EXHIBIT 10.14
EX-10.15
v427012_ex10-15.htm
EXHIBIT 10.15
EX-10.16
v427012_ex10-16.htm
EXHIBIT 10.16
EX-10.17
v427012_ex10-17.htm
EXHIBIT 10.17
EX-10.18
v427012_ex10-18.htm
EXHIBIT 10.18
EX-10.19
v427012_ex10-19.htm
EXHIBIT 10.19
EX-10.20
v427012_ex10-20.htm
EXHIBIT 10.20
EX-10.21
v427012_ex10-21.htm
EXHIBIT 10.21
EX-10.22
v427012_ex10-22.htm
EXHIBIT 10.22
EX-10.23
v427012_ex10-23.htm
EXHIBIT 10.23
EX-10.24
v427012_ex10-24.htm
EXHIBIT 10.24
EX-10.25
v427012_ex10-25.htm
EXHIBIT 10.25
EX-10.26
v427012_ex10-26.htm
EXHIBIT 10.26
EX-10.27
v427012_ex10-27.htm
EXHIBIT 10.27
EX-10.28
v427012_ex10-28.htm
EXHIBIT 10.28
EX-21.1
v427012_ex21-1.htm
EXHIBIT 21.1
EX-23.1
v427012_ex23-1.htm
EXHIBIT 23.1
EX-23.3
v427012_ex23-3.htm
EXHIBIT 23.3
GRAPHIC
logo_gfk.jpg
GRAPHIC
GRAPHIC
line.gif
GRAPHIC
GRAPHIC
spacer.gif
GRAPHIC
GRAPHIC
logo_cancer-prevention.jpg
GRAPHIC
GRAPHIC
v425296_chrt-table.jpg
GRAPHIC
GRAPHIC
v425296_img-fap.jpg
GRAPHIC
GRAPHIC
v425296_img-mutationapc.jpg
GRAPHIC
GRAPHIC
v419229_chrt-org1.jpg
GRAPHIC
GRAPHIC
v419229_chrt-bar1.jpg
GRAPHIC
GRAPHIC
v419229_chrt-bar2.jpg
GRAPHIC
GRAPHIC
v425296_chrt-bar1.jpg
GRAPHIC
GRAPHIC
v425296_chrt-org2.jpg
GRAPHIC
GRAPHIC
v425296_chrt-orgphase3.jpg
GRAPHIC
GRAPHIC
tex4-8_logo.jpg
GRAPHIC
GRAPHIC
tex4-8_pg1.jpg
GRAPHIC
GRAPHIC
tex4-8_cpplogo.jpg
GRAPHIC
GRAPHIC
tex4-8_cppfooter.jpg
GRAPHIC
GRAPHIC
tex10-5_logo.jpg
GRAPHIC
GRAPHIC
tex10-7_logo.jpg
GRAPHIC
GRAPHIC
tex10-8_logo.jpg
GRAPHIC
GRAPHIC
tex10-9_logo.jpg
GRAPHIC
GRAPHIC
tex10-10_header.jpg
GRAPHIC
GRAPHIC
tex10-10_footer.jpg
GRAPHIC
GRAPHIC
image_001.jpg
GRAPHIC
GRAPHIC
tlogoex10-28.jpg
GRAPHIC

Issuer

Cancer Prevention Pharmaceuticals, Inc.

CIK 0001471002

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001471002

Filing Metadata

Form type: S-1
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 22, 9:56 PM ET
Size: 10.0 MB

View on SEC.gov